Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Görünümler
• 07/17/23
0
0
gömmek
administrator
Aboneler
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar